On December 10, Jilin Aodong (000623) announced that the company held on the same day the board of directors and board of supervisors meeting,on which a new proposal was reviewed and approved. In order to occupy the cooperation opportunities with quick layout, maximize the company’s advantage of market development ability, sales channels and capital in pharmaceutical field, and make full use of Thousand Talents Program Innovative Drug and Food Safety Research Center Yangzhou Co., Ltd and Mr. Wang Fei’s R&D expertise and seniority advantage in foods for special medical purposes, Jilin Aodong has approved to invest 80million yuan of its own capital together with the 53.33million yuan investment of Thousand Talents Program Innovative Drug and Food Safety Research Center Yangzhou Co., Ltd to jointly set up Jilin boyate medical nutrition technology co., LTD. (the specific name shall be subjected to the actural business registration), focusing on foods for special medical purposes.

The announcement shows that this overseas investment will make full use of the research and development ability, experience and seniority advantage of the partner in the industry of foods for special medical purposes, accelerate the company's layout in this industry, optimize the company's strategic layout, and further improve its competitiveness.